应用合成生物学构建蓝细菌细胞工厂的研究进展

蓝细菌是一类能进行放氧光合作用的原核微生物,具有生长速度快、光合效率高、易于基因遗传操作等特点。它们能够将捕获的光能和二氧化碳转化为生物能源分子,在解决当前社会面临的能源紧缺和环境污染等问题上有着重要的理论和应用研究价值。近年来,随着合成生物学的迅猛发展,构建以蓝细菌为底盘的“人工细胞工厂”用于合成各类生物能源和精细化学产品取得了令人瞩目的成绩。重点介绍了应用合成生物学构建蓝细菌细胞合成工厂的研究进展,并对“光合自养型细胞工厂”面临的两大问题——产物毒性问题以及细胞内氧化胁迫问题进行了重点讨论。     

应用合成生物学策略优化光合蓝细菌底盘

光合蓝细菌具有一系列良好的特质,包括利用太阳能固定CO2、营养需求低、生长迅速以及遗传背景简单等.近年来,光合蓝细菌作为生产可再生燃料和精细化学制品的“自养型人工细胞工厂”引起了社会的广泛关注,促进了相关研究的升温.目前在应用合成生物学的技术和研究策略来优化光合蓝细菌作为底盘生物等方面已取得了一些令人鼓舞的进展.文中综述了近年来在光合蓝细菌底盘优化的方法、光合效率的提高以及各种耐受性蓝细菌底盘的构建方面的进展,并对光合蓝细菌底盘构建的工业应用价值进行了讨论.     

蓝细菌乙醇光合细胞工厂的发展与展望

生物乙醇是极具应用潜力和代表性的生物能源产品之一。以蓝细菌为光合平台,利用二氧化碳和太阳能直接进行乙醇合成可以同时起到降低二氧化碳排放和提供可再生能源的效果,具有重要的研究与应用价值。本文回顾了蓝细菌乙醇光合细胞工厂相关技术的发展历程和现状,从途径优化、底盘选择和代谢工程策略等层面对其最新进展和所遇到的问题进行了总结介绍,并对该技术未来发展方向进行了展望。     

基于糖原代谢调控的蓝细菌光合细胞工厂优化研究进展

蓝细菌是重要的光合自养微生物,也是最具潜力的光合微生物底盘之一,被广泛应用于光驱固碳细胞工厂的开发.糖原是蓝细菌最重要的天然碳汇物质,糖原代谢对蓝细菌光合碳流的分配和调控具有重要意义.为了优化蓝细菌光合细胞工厂的合成效能,驱动更多的光合碳流重定向至目标代谢产物的合成,已经有多种策略和方法被成功开发用于调控蓝细菌的糖原代...     

实验室适应性进化技术在光合蓝细菌底盘工程中的研究进展

蓝细菌是唯一可进行放氧光合作用的原核微生物,基于光合蓝细菌构建“自养型细胞工厂”具有广阔前景。但以蓝细菌作为底盘进行生物燃料及化学品的合成仍存在细胞耐受能力差、产量低等问题,导致实现工业化生产的经济可行性还比较低,亟需通过合成生物学等技术手段构建新的藻株。近年来,实验室适应性进化(adaptive laboratory evolution,ALE)已被用于底盘工程中,实现了优化生长速度、增加耐受性、加强底物利用和提高产品产量等目标。ALE在提高蓝细菌鲁棒性方面取得了一定进展,已获得了耐受高光、重金属离子、高盐和高浓度有机溶剂胁迫的进化藻株。但是,蓝细菌中的ALE策略效率相对较低,耐受各胁迫的分子机制并未阐释完全。本文综述了ALE相关技术策略及其在蓝细菌底盘工程中的应用,讨论了如何借鉴其他微生物中ALE手段,构建更大ALE突变文库、增加菌株的突变频率、缩短进化时间、探索多重胁迫耐受工程菌构建原则及研究策略等,高效解析进化菌株的突变体库,构建高产量、鲁棒性强的工程菌株等,以期未来促进蓝细菌底盘的改造及其工程菌的规模化应用。     

生物炼制细胞工厂:生物制造的技术核心

对生物炼制细胞工厂的发展进行了简要回顾,从微生物糖代谢的分子机制、细胞工厂的代谢网络及调控、细胞工厂的构建技术及细胞工厂的优化4个方面介绍了本期专刊发表的17篇生物炼制细胞工厂方面的论文。     

合成生物学在微生物细胞工厂构建中的应用

通过微生物发酵的方法生产大宗化学品和天然产物能够部分替代石油化工炼制和植物提取。合成生物学技术的发展极大地提高了构建微生物细胞工厂生产大宗化学品和天然产物的能力。一方面综述了合成生物学在构建细胞工厂时的关键技术,包括最优合成途径的设计、合成途径的创建与优化、细胞性能的优化;另一方面,介绍了应用这些技术构建细胞工厂生产燃料化学品、大宗化学品和天然产物的典型案例。     

蓝细菌基因组拷贝数的研究进展与展望

蓝细菌是一类古老的光合原核微生物。就基因组拷贝数(倍性)而言,蓝细菌是原核生物中基因组低、中、高拷贝共存的典型类群之一,而基因组多拷贝特性是制约蓝细菌高效遗传改造的瓶颈。已有研究表明,蓝细菌的基因组拷贝数表现出生长周期的依赖性并受多种遗传、环境因子的影响。文中综述了蓝细菌基因组拷贝数的国内外最新研究进展、分析方法及影响因素,并讨论了蓝细菌基因组多拷贝研究的环境生态和生物技术意义。最后,对未来蓝细菌基因组拷贝数相关的研究方向作出展望。     

非常规酵母细胞工厂合成天然产物

天然产物在医药、美容、食品等行业具有重要的应用,随着人们需求的增加,迫切需要绿色可持续的生产过程.近年来,微生物细胞工厂合成天然产物发展迅速,目前常用的细胞工厂宿主包括大肠杆菌和酿酒酵母.与此同时,非常规酵母因其性状独特,如高密度有氧发酵、耐受温度和pH范围广,底物谱广泛(长链糖、脂肪酸、甲醇等),逐渐成为极具潜力的细...     

非天然氨基酸细胞工厂的构建与应用

非天然氨基酸在医药、农药、材料等领域得到广泛应用,其绿色、高效合成越来越受到关注.近年来,随着合成生物学的快速发展,微生物细胞工厂为非天然氨基酸的制造提供了重要手段.文中从合成途径的重构、关键酶的设计改造及与前体的协同调控、竞争性旁路途径的敲除、辅因子循环系统的构建等方面介绍了 一系列非天然氨基酸细胞工厂构建与应用的研...     

毕赤酵母细胞工厂工程化改造与应用

毕赤酵母作为细胞工厂在小分子代谢产物发酵和蛋白制品生物合成中扮演着重要角色,具有极其重要的工业应用价值。随着CRISPR/Cas9等新型编辑工具的开发和应用,对毕赤酵母细胞工厂进行多基因高效率的工程化改造已成为可能。本文首先对毕赤酵母工程化改造的遗传操作技术和目标方向进行了归纳总结,其次介绍了毕赤酵母作为细胞工厂的应用现状,同时探讨了毕赤酵母细胞工厂的优点及缺陷,并对其发展方向作出展望;以期为未来的毕赤酵母工程化改造研究提供参考和启示,推动毕赤酵母细胞工厂在生物产业中的创新应用。     

The cell factory approach toward biotechnological production of high-value chitosan oligomers and their derivatives: an update

Chitin is one of the most abundant renewable resources, and chitosans, the partially deacetylated derivatives of chitin, are among the most promising functional biopolymers, with superior material properties and versatile biological functionalities. Elucidating molecular structure–function relationships and cellular modes of action of chitosans, however, it is challenging due to the micro-heterogeneity and structural complexity of polysaccharides. Lately, it has become apparent that many of the biological activities of chitosan polymers, such as in agricultural plant disease protection or in mediating scar-free wound healing, may be attributed to oligomeric break-down products generated by the action of chitosanolytic hydrolases present in the target tissues, such as human chitotriosidase. Consequently, the focus of current research is shifting toward chitosan oligomers so that the availability of well-defined chitosan oligosaccharides (COS) becomes a bottleneck. Well-known ways of producing COS use physical and/or chemical means for the partial depolymerization of chitosan polymers, typically leading to broad mixtures of COS varying in their degrees of polymerization (DP) and acetylation (DA), and with more or less random patterns of acetylation (PAs). Even after chromatographic separation according to DP and DA, such mixtures are of limited value to elucidate structure–function relationships and modes of action. More recently, enzymatic means using chitinases and/or chitosanases, and sometimes chitin deacetylases, have been proposed as these can be more tightly controlled and yield slightly better defined mixtures of COS. An alternative would be chemical synthesis of COS which in principle would allow for full structural control, but protocols for it are lengthy, costly, and not yet well developed, and yields are low. Synthetic biology now allows to develop today’s in vitro bio-refinery approaches into in vivo cell factory approaches for the biotechnological production of defined COS using recombinant microbial strains expressing chitin oligomer synthases and chitin oligomer deacetylases. In this review, we will describe the state-of-the-art of this cell factory approach, as a basis for upcoming developments. We will briefly describe traditional chemical protocols and enzymatic production of COS as a background to the more detailed presentation of what has been achieved through in vivo biosynthesis. We will only briefly describe those as a background to the more detailed presentation of what has been achieved through in vivo biosynthesis. We will also touch on the production of COS derivatives that has been achieved in this way, as these oligomers open up another plethora of potential applications when used as building blocks for defined biomaterials.     

Engineering the plant cell factory for secondary metabolite production

Plant secondary metabolism is very important for traits such as flower color, flavor of food, and resistance against pests and diseases. Moreover, it is the source of many fine chemicals such as drugs, dyes, flavors, and fragrances. It is thus of interest to be able to engineer the secondary metabolite production of the plant cell factory, e.g. to produce more of a fine chemical, to produce less of a toxic compound, or even to make new compounds, Engineering of plant secondary metabolism is feasible nowadays, but it requires knowledge of the biosynthetic pathways involved. To increase secondary metabolite production different strategies can be followed, such as overcoming rate limiting steps, reducing flux through competitive pathways, reducing catabolism and overexpression of regulatory genes. For this purpose genes of plant origin can be overexpressed, but also microbial genes have been used successfully. Overexpression of plant genes in microorganisms is another approach, which might be of interest for bioconversion of readily available precursors into valuable fine chemicals. Several examples will be given to illustrate these various approaches. The constraints of metabolic engineering of the plant cell factory will also be discussed. Our limited knowledge of secondary metabolite pathways and the genes involved is one of the main bottlenecks. This revised version was published online in August 2006 with corrections to the Cover Date.     

谷氨酸棒杆菌耐受胁迫机制及工业鲁棒性合成生物学研究进展

谷氨酸棒杆菌Corynebacterium glutamicum作为一般被认为具有生物安全性的一种模式工业微生物,不仅在发酵工业中成功用于大规模生产氨基酸,而且具有合成多种新型化学品的潜力。谷氨酸棒杆菌菌株在生产化合物时,经常会受到各种逆境条件的胁迫,从而降低细胞活力和生产性能。合成生物学的发展为提高谷氨酸棒杆菌的鲁棒性提供了新的技术手段。本文总结了谷氨酸棒杆菌应对发酵过程中各种胁迫的耐受机制。同时,重点介绍提高谷氨酸棒杆菌底盘细胞鲁棒性和耐受性的合成生物学新策略,包括挖掘新的抗逆元件、改造转录调控因子、利用适应性进化策略挖掘抗逆功能模块等。最后,从生物传感器、转录调控因子的筛选和设计、多种调控元件利用等方面对提高谷氨酸棒杆菌底盘细胞鲁棒性进行了展望。     

Development of GRAS strains for nutraceutical production using systems and synthetic biology approaches: advances and prospects

Nutraceuticals are food substances with medical and health benefits for humans. Limited by complicated procedures, high cost, low yield, insufficient raw materials, resource waste, and environment pollution, chemical synthesis and extraction are being replaced by microbial synthesis of nutraceuticals. Many microbial strains that are generally regarded as safe (GRAS) have been identified and developed for the synthesis of nutraceuticals, and significant nutraceutical production by these strains has been achieved. In this review, we systematically summarize recent advances in nutraceutical research in terms of physiological effects on health, potential applications, drawbacks of traditional production processes, characteristics of production strains, and progress in microbial fermentation. Recent advances in systems and synthetic biology techniques have enabled comprehensive understanding of GRAS strains and its wider applications. Thus, these microbial strains are promising cell factories for the commercial production of nutraceuticals.     

Engineering a cyanobacterial cell factory for production of lactic Acid

Metabolic engineering of microorganisms has become a versatile tool to facilitate production of bulk chemicals, fuels, etc. Accordingly, CO(2) has been exploited via cyanobacterial metabolism as a sustainable carbon source of biofuel and bioplastic precursors. Here we extended these observations by showing that integration of an ldh gene from Bacillus subtilis (encoding an l-lactate dehydrogenase) into the genome of Synechocystis sp. strain PCC6803 leads to l-lactic acid production, a phenotype which is shown to be stable for prolonged batch culturing. Coexpression of a heterologous soluble transhydrogenase leads to an even higher lactate production rate and yield (lactic acid accumulating up to a several-millimolar concentration in the extracellular medium) than those for the single ldh mutant. The expression of a transhydrogenase alone, however, appears to be harmful to the cells, and a mutant carrying such a gene is rapidly outcompeted by a revertant(s) with a wild-type growth phenotype. Furthermore, our results indicate that the introduction of a lactate dehydrogenase rescues this phenotype by preventing the reversion.     

Aspergillus as a versatile cell factory for organic acid production

Filamentous fungi from the genus Aspergillus are of high importance for biobased organic acid production. So far, a number of Aspergillus strains belonging to phylogenetically distantly related species have been successfully applied in industrial production of organic acids due to their excellent capabilities of secreting high amounts of desired organic acids. For the past decades, numerous efforts have been made to reveal the mechanisms of organic acid biosynthesis in several Aspergillus species and to improve the production of desired organic acids via genetic engineering. This review summarizes the recent breakthroughs in the fundamental understanding of physiological aspects of organic acid accumulation by fungal biocatalysts and highlights the progress in genetic engineering of aspergilli for organic acid production. The challenges for the future applications of aspergilli as commercial cell factories for organic acid production are also discussed.     

合成生物学时代基于非模式细菌的工业底盘细胞研究现状与展望

工业微生物底盘细胞的开发将为工业生物技术的发展提供优良的细胞工厂,有利于实现环境保护及经济可持续发展.基于合成生物学"设计-构建-测试-学习"(Design-Build-Test-Learn,DBTL)策略,对底盘细胞进行多维度的理性或半理性改造是实现"建物致知"以及"建物致用"目标的重要手段.文中简述了合成生物学DB...